Category : Search result: media funding


AI Gold Rush: Are Tech Valuations Defying Gravity?

As artificial intelligence companies achieve staggering multi-billion dollar valuations, experts question whether this represents genuine innovation or dangerous market speculation that could reshape global economics.

ANU buys Israeli arms shares despite ethical pledge

The Australian National University faces backlash after investing in Israeli weapons manufacturer Elbit Systems, directly contradicting its public commitment to divest from controversial arms companies.

Ex-Telegraph journalist joins Financial News team

Financial News bolsters its editorial team with the appointment of Harry Brennan, an experienced journalist from The Telegraph, to enhance coverage of London's professional services sector

US Veterans Benefits Face Funding Crisis

Exclusive investigation reveals how millions of American veterans could lose crucial financial support as key government benefit programme faces imminent funding crisis.

Joey Barton on trial over social media posts

Former footballer Joey Barton is on trial accused of sending offensive messages about female pundits, with prosecutors arguing he crossed from free speech into criminal behaviour.

UK bans strangulation in pornography

The UK government is criminalising the depiction of strangulation and choking in pornography, with creators facing prosecution under new legislation targeting 'dangerous and harmful' content.

Guardian Issues Corrections for Reporting Errors

The Guardian's latest corrections roundup reveals significant errors in reporting, from misidentified locations to factual inaccuracies in political coverage. Discover what the newspaper had to set straight.

Khan fights 'no-go zone' myths about UK cities

London Mayor Sadiq Khan confronts what he describes as a dangerous misinformation campaign by right-wing agitators deliberately portraying UK cities as lawless 'no-go zones'.

Big Pharma's Tax Breaks: Are We Getting NHS Value?

Exclusive analysis reveals pharmaceutical giants received massive tax incentives while NHS faces funding crisis. Experts demand transparency on whether these breaks are delivering promised benefits to UK healthcare.

Page 1 of 4